It's quite natural for mass tort cases to proceed under multidistrict litigation, |
It's quite natural for mass tort cases to proceed under multidistrict litigation. |
It's still too early. We just don't have the patterns yet. |
It's too early to tell. Some people believe that Roberts may be similar to Rehnquist in his jurisprudence, although that's not at all clear yet. |
It's too soon to say Merck has momentum. Many people felt the Irvin case was a weak case to begin with. It was a short-term usage case. |
It's very difficult for Specter to thread the needle, because of all the obligations he has, ... There's substantial pressure on him because of the issue of reproductive freedom. |
Juries frequently confront contradictory information, especially in criminal trials. Juries then must sort through all of the evidence, sift and weigh it, resolve the contradictions as best they can, and reach a determination. |
Merck is trying to paint this as a tie, but it is really not so good for them because people thought they would have had an easy win. |
More and more people who have been injured or think they've been injured come forward. It takes on a life of its own. |
Most people predicted this but it wasn't a forgone conclusion. |
Most people watching this litigation closely thought that Merck ought to win it. Despite the characterizations by Merck so far, I think this was really a loss for them. |
Negligence is much easier to prove; it's the failure to exercise reasonable care. Willful misconduct is a much higher standard. You must intentionally misbehave. ... The high standard would clearly discourage many suits. |
One case does not a whole litigation strategy make. |
Right now it seems like the uncertainty would make senators more circumspect with Roberts. |
Senators want to know, `Does she have an overarching theory of jurisprudence? How would she approach cases?' |